Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study.

Karina Dahl Steffensen, Marianne Waldstrom, Niels Pallisgård, Bente Lund, Kjell Bergfeldt, Jessica Wihl, Nina Keldsen, Christian Marth, Ignace B. Vergote, Anders Kristian Moeller Jakobsen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2012
Externally publishedYes
EventAmerican Society of Clinical Oncology - Chicago, United States
Duration: 1 Jun 20125 Jun 2012
Conference number: 48


ConferenceAmerican Society of Clinical Oncology
CountryUnited States

Bibliographical note

PT: J; CT: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); CY: JUN 01-06, 2012; CL: Chicago, IL; SP: Amer Soc Clin Oncol (ASCO); NR: 0; TC: 0; J9: J CLIN ONCOL; SU: S; PG: 1; GA: 131QQ; UT: WOS:000318009803644


  • Oncology

Cite this